Skip to content

Evaluation of Novel Lung Function Parameters in Patients With Pulmonary Hypertension (PH)

Evaluation of Novel Lung Function Parameters in Patients With Pulmonary Hypertension (PH)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03667794
Enrollment
75
Registered
2018-09-12
Start date
2015-07-01
Completion date
2017-07-31
Last updated
2018-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Hypertension

Brief summary

Little is known about affection of small airways in patients with pulmonary hypertension as well as the ideal diagnostic approach. The investigators therefore aimed to evaluate novel or not widely used lung function tests for the evaluation of airway function in patients with PH.

Interventions

measurement of ventilation heterogeneity

DIAGNOSTIC_TESTbody plethysmography

measurement of conventional lung function parameters

DIAGNOSTIC_TESTimpulse oscillometry

measurement of central and peripheral airway resistance

Sponsors

Universitätsmedizin Mannheim
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* known or first diagnosis of PH

Exclusion criteria

* inability to perform lung function testing * unable or unwilling to participate

Design outcomes

Primary

MeasureTime frameDescription
LCI30 minutesbetween-group difference in lung clearance index (LCI)
D5-2030 minutesbetween-group difference in frequency dependence of resistance (D5-20)

Secondary

MeasureTime frameDescription
Discrimination small airway resistance30 minutesEvaluation of discriminative capability of impulse oscillometry
Discrimination ventilation heterogeneity30 minutesEvaluation of discriminative capability of multiple breath washout

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026